5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Epigral Ltd.

•
epigral.comBSE: 543332NSE: EPIGRAL
Market Cap₹ 4,870 Cr.
Current Price
High / Low₹ 1,809 / 807
Stock P/E18.0
Book Value₹ 538
Price to Book1.57
Dividend Yield0.44 %
ROCE15.7 %
ROE16.1 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence
55%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 26.9% CAGR over last 5 years
  • Company has consistently been profitable over the last 5 years
  • Company has delivered good sales growth of 25.0% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.44x)
  • Working capital cycle has improved - days down from 38 to 16
  • Company generates healthy free cash flow

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Recent results are weak - TTM profit is down 45.3% versus prior year
  • Promoter holding has decreased over last 2 years: -2.8pp
  • Operating margins have contracted to 21.2% from 30.1%
  • Growth is decelerating - 3Y profit CAGR (-2.1%) trails the 5Y trend (26.9%)
  • Though reporting repeated profits, the company pays out little dividend (6.5%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsChemicalsChemicals
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SOLARINDS22307.50101.37201860.690.05666.3788.983668.2070.2638.1627.91
2.PIDILITIND1567.4560.23159547.551.378835.101202.8645515.501112.7432.3826.28
3.SRF2483.0034.0573602.280.36758.8775.535033.2634.6314.2124.57
4.FLUOROCHEM4771.7585.2352417.670.06219.0019.021588.0023.979.5826.83
5.NAVINFLUOR8541.1055.4943822.770.18243.31107.671045.0844.0721.3934.17
6.GODREJIND1127.0032.2937963.110.00523.36-27.855448.0922.1610.6412.82
7.AETHER1672.9594.4122204.700.0062.7533.45326.5627.4911.6531.47
8.DEEPAKNTR1587.1027.6421646.940.47345.01207.362577.6036.3911.5820.96
9.ATUL6244.5523.1118385.050.48253.9391.851847.9525.0315.0521.41
10.AARTIIND492.1533.6217851.590.20155.00260.472387.0042.426.9516.00
11.DEEPAKFERT1320.4517.0016725.200.76490.04100.953256.2622.4712.1225.96
12.EPIGRAL1128.8017.974869.790.4499.74-37.93705.3616.2915.6525.48
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
455478472525651626645628607587597736705
360370349369475448463454443455494568576
Operating Profit95108123155176178183173163132103169129
OPM %20.93%22.57%26.04%29.62%27.09%28.50%28.29%27.62%26.94%22.53%17.21%22.90%18.30%
21222643826-14
Interest182120141427-012232211167
Depreciation31323130333233344242434243
Profit before Tax4856741131311241541311077055111134
Tax %33.42%31.98%33.51%32.06%34.39%35.27%32.56%33.91%-50.30%26.35%28.30%25.87%25.42%
Net Profit0000868110487161513981100
7.589.1411.8118.6020.6719.5724.2520.1437.2511.879.0718.7623.12

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
8291,5512,1881,9292,5502,5272,626
5671,0411,4991,4481,8391,9602,093
Operating Profit261509689481711567533
OPM %31.54%32.85%31.48%24.94%27.87%22.44%20.29%
7897151511
Interest34486773537256
Depreciation7486109124133168170
Profit before Tax161383522291541341369
Tax %37.31%34.07%32.38%32.63%33.89%2.58%26.16%
Net Profit101253353196358332272
EPS17.2660.8485.0347.1482.9176.95—
Dividend Payout %0.00%0.00%5.88%10.61%7.24%6.50%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
25%
3 Years:
5%

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
27%
3 Years:
-2%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
4%
1 Year:
-37%

RETURN ON EQUITY

10 Years:
—
5 Years:
27%
3 Years:
19%
Last Year:
16%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

Jun 1

₹ 0.50

Rs.5.0000 per share(50%)Final Dividend

2025

Jun 20

₹ 0.35

Rs.3.5000 per share(35%)Final Dividend

2025

Feb 7

₹ 0.25

Rs.2.5000 per share(25%)Interim Dividend

2024

Jul 2

₹ 0.50

Rs.5.0000 per share(50%)Final Dividend

2023

Jun 20

₹ 0.25

Rs.2.5000 per share(25%)Final Dividend

2023

Feb 1

₹ 0.25

Rs.2.5000 per share(25%)Interim Dividend

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
424242424343
4326841,0281,2131,8612,178
419851878768505466
Trade Payables7388110184186260
483459375588557559
Total Liabilities1,4492,1242,4322,7943,1523,505
1,1021,0681,8041,7672,2382,117
Capital Work in Progress12658915848364451
0021219823
54154212263388349
000179232417
Cash & Bank125157225
16628722376110144
Total Assets1,4492,1242,4322,7943,1523,505

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
258344734398441436
Cash from Investing-197-455-437-401-262-355
Cash from Financing-32195-200-8-164-94
124-11-1115-14

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
71.5871.5868.9468.9568.8368.8368.8368.8368.83
1.462.103.013.013.062.712.361.541.03
0.181.174.314.664.784.925.134.905.56
0.020.020.020.020.020.020.020.020.02
26.7425.1323.7223.3523.3123.5223.6624.7024.55

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-31
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-31 - Epigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday, 03.09.2026

2026-08-18
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-18 - Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday, 20.08.2026

2026-08-07
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-07 - Epigral Limited has informed the Exchange about participation in EMKAY Confluence 2026 on 12th August, 2026

2026-07-30
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-30 - Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on Monday, 3rd August, 2026.

2026-07-30
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-30 - Epigral Limited has informed the Exchange about Transcript

2026-07-29
Copy of Newspaper Publication

2026-07-29 - Epigral Limited has informed the Exchange about Copy of Newspaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026

2026-07-27
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-27 - Epigral Limited has informed the Exchange about Link of Recording

2026-07-27
Investor Presentation

2026-07-27 - Epigral Limited has informed the Exchange about Investor Presentation

2026-07-27
Press Release

2026-07-27 - Epigral Limited has informed the Exchange regarding a press release dated July 27, 2026, titled "Press Release on Un-Audited Financial Results Q1 FY27".

News

Recent coverage and analyst commentary for EPIGRAL

Loading news…

🤖

AI Stock Analyst

Epigral Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login